Could a cancer drug help beat malaria? new trial aims to stop drug-resistant parasites
NCT ID NCT07559370
First seen May 05, 2026 · Last updated May 25, 2026 · Updated 4 times
Summary
This study tests whether adding imatinib (a cancer drug) to the standard malaria treatment can clear the parasite faster and prevent drug resistance. About 1,100 adults with mild to moderate malaria will receive either the standard 3-day treatment or a shorter 2-day combo. The goal is to see if the combo is safe, works faster, and reduces the chance of the infection coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Victoria Biomedical Research Institute
RECRUITINGKisumu, 40100, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.